IT1396937B1 - Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea - Google Patents

Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea

Info

Publication number
IT1396937B1
IT1396937B1 ITMI2009A002083A ITMI20092083A IT1396937B1 IT 1396937 B1 IT1396937 B1 IT 1396937B1 IT MI2009A002083 A ITMI2009A002083 A IT MI2009A002083A IT MI20092083 A ITMI20092083 A IT MI20092083A IT 1396937 B1 IT1396937 B1 IT 1396937B1
Authority
IT
Italy
Prior art keywords
bisphosphonates
intramuscular
vitamin
subcutaneous
formulations
Prior art date
Application number
ITMI2009A002083A
Other languages
English (en)
Inventor
Tiberio Bruzzese
Original Assignee
Bruzzese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruzzese filed Critical Bruzzese
Priority to ITMI2009A002083A priority Critical patent/IT1396937B1/it
Priority to EP10794865.5A priority patent/EP2503992B1/en
Priority to PCT/EP2010/007140 priority patent/WO2011063952A1/en
Priority to US13/511,923 priority patent/US20120322767A1/en
Priority to ES10794865.5T priority patent/ES2592155T3/es
Publication of ITMI20092083A1 publication Critical patent/ITMI20092083A1/it
Application granted granted Critical
Publication of IT1396937B1 publication Critical patent/IT1396937B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
ITMI2009A002083A 2009-11-26 2009-11-26 Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea IT1396937B1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI2009A002083A IT1396937B1 (it) 2009-11-26 2009-11-26 Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea
EP10794865.5A EP2503992B1 (en) 2009-11-26 2010-11-25 Formulations of bisphosphonates and vitamin d suitable for intermittent intramuscular and subcutaneous administration
PCT/EP2010/007140 WO2011063952A1 (en) 2009-11-26 2010-11-25 Formulations of bisphosphonates and vitamin d suitable for intermittent intramuscular and subcutaneous administration
US13/511,923 US20120322767A1 (en) 2009-11-26 2010-11-25 Formulations of bisphosphonates and vitamin d suiutable for intermittent intramuscular and subcutaneous administration
ES10794865.5T ES2592155T3 (es) 2009-11-26 2010-11-25 Formulaciones de bisfosfonatos y vitamina D adecuadas para administración intramuscular y subcutánea intermitente

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A002083A IT1396937B1 (it) 2009-11-26 2009-11-26 Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea

Publications (2)

Publication Number Publication Date
ITMI20092083A1 ITMI20092083A1 (it) 2011-05-27
IT1396937B1 true IT1396937B1 (it) 2012-12-20

Family

ID=42316047

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A002083A IT1396937B1 (it) 2009-11-26 2009-11-26 Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea

Country Status (5)

Country Link
US (1) US20120322767A1 (it)
EP (1) EP2503992B1 (it)
ES (1) ES2592155T3 (it)
IT (1) IT1396937B1 (it)
WO (1) WO2011063952A1 (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2640094C (en) 2006-02-03 2015-04-14 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PT3357496T (pt) 2006-06-21 2020-05-12 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
JP5501956B2 (ja) 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物
CN101668532B (zh) 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US8968790B2 (en) 2011-12-09 2015-03-03 Shaker A. Mousa Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
US20150018237A1 (en) * 2012-02-15 2015-01-15 Basf Se Means and methods for assessing bone disorders
ITMI20120393A1 (it) * 2012-03-14 2013-09-15 Tiberio Bruzzese Formulazioni acquose di bisfosfonati, vitamina d e alcol benzilico adatte all'uso intramuscolare o sottocutaneo
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
PT106978A (pt) * 2013-05-31 2014-12-02 Tecnimede Sociedade Tecnico Medicinal S A Composição sólida oral contendo ácido ibandrónico e vitamina d
US9387151B2 (en) 2013-08-20 2016-07-12 Anutra Medical, Inc. Syringe fill system and method
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
CN105748488A (zh) * 2014-12-20 2016-07-13 重庆布尔动物药业有限公司 兽用复合维生素注射液及其制备方法
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Treatment methods using vitamin D
KR101833362B1 (ko) * 2017-09-29 2018-02-28 대한뉴팜(주) 안정성이 향상된 콜레칼시페롤 조성물 및 이의 제조방법
KR102011714B1 (ko) * 2018-01-16 2019-08-19 동국제약 주식회사 리세드론산 또는 그의 염 및 비타민d를 함유하는 경구용 에멀젼 조성물 및 그 제조방법
KR102556874B1 (ko) * 2018-02-14 2023-07-18 동국제약 주식회사 비스포스포네이트 및 콜레칼시페롤을 함유하는 경구용 에멀젼 조성물 및 그 제조방법
CN111629599A (zh) * 2018-02-19 2020-09-04 雅培制药有限公司 脂质乳剂营养产品
CN115154423B (zh) * 2022-08-05 2024-02-23 四川尚锐生物医药有限公司 一种伊班膦酸钠注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176685A1 (en) 2002-04-05 2005-08-11 Daifotis Anastasia G. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
ITMI20032175A1 (it) * 2003-11-11 2005-05-12 Tiberio Bruzzese Formulazioni farmaceutiche di bisfosfonati destinate
BRPI0616330A2 (pt) * 2005-09-26 2011-06-14 Novacea Inc prevenÇço e tratamento de distérbios gastrintestinais e da bexiga associados com quimioterapia ou radioterapia usando compostos ativos com vitamina d
EP1972341A1 (en) * 2007-03-23 2008-09-24 Novartis AG Pharmaceutical compositions comprising a bisphosphonate and vitamin D

Also Published As

Publication number Publication date
ITMI20092083A1 (it) 2011-05-27
EP2503992A1 (en) 2012-10-03
EP2503992B1 (en) 2016-04-20
WO2011063952A8 (en) 2011-09-01
ES2592155T3 (es) 2016-11-28
US20120322767A1 (en) 2012-12-20
WO2011063952A1 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
IT1396937B1 (it) Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea
SMT201600079B (it) Composizioni per somministrazione mirata di sirna
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
HK1201483A1 (en) Devices for targeted delivery of therapeutic implants
DK2726141T3 (da) Enhed til oral levering af terapeutiske forbindelser
SMT201600338B (it) Formulazioni farmaceutiche comprendenti derivati di1-(beta-d- glucopiranosil)- 2-tienilmetilbenzene come inibitori di sglt
DK3447061T3 (da) Farmaceutisk formulering omfattende et phosphoramidatderivat af 5-fluor-2'-deoxyuridin til anvendelse i cancerbehandling
DK3170508T3 (da) Vaccineformuleringer
DK2641614T3 (da) Farmaceutisk præparat integreret med mikronåle til hudbehandling
SMT201400044B (it) Formulazione di impianto di paliperidone
DK2525798T3 (da) Anæstetisk formulering
SG11201401329VA (en) Improved formulations for drug-coated medical devices
SMT201600341B (it) Soluzione per somministrazione orale
CO6940426A2 (es) Formulaciones farmacéuticas
ZA201403195B (en) Pharmaceutical compositions of hydrophobic camptothecin derivatives
SMT201600036B (it) Metodo per la preparazione e il miglioramento di ferri di cavallo
ZA201109514B (en) Method of drug delivery
EP2744441A4 (en) DENTAL IMPLANTS - CUSTOM PILLAR REPLICAS AND IMPLANT ANALOGS
FR2972625B1 (fr) Implant dentaire
BR112013030365A2 (pt) composições para administração percutânea de princípio ativo fisiologicamente
ES1070842Y (es) Jeringa medicinal autodesechable de bioseguridad
EP2699094A4 (en) TASTE-MASKED FORMULATIONS BY RALTEGRAVIR
PL2585041T3 (pl) Preparat farmaceutyczny o zamaskowanym smaku o przyspieszonym początku działania
DK2407154T3 (da) Formuleringer af 14-epi-analoger af D-vitamin